FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/035291 [Registered on: 30/07/2021] Trial Registered Prospectively
Last Modified On: 15/09/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A Clinical Trial to study the effect of two drugs, Bhumyamalaki and Kali Maricha in patients with Diabetes Mellitus (Madhumeha) 
Scientific Title of Study   A Clinical Study to evaluate the effect of combination of Bhumyamalaki ( Phyllanthus niruri) and Kali Maricha ( Piper nigrum) on Madhumeha WSR to Diabetes Mellitus  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rosy Gupta 
Designation  Reader 
Affiliation  Post Graduate Training and Research Institute Government Ayurvedic College Patiala 
Address  Reader in Post Graduate Training and Research Institute Government Ayurvedic College Patiala
Post Graduate Training and Research Institute Government Ayurvedic College Patiala
Patiala
PUNJAB
147001
India 
Phone  9815818190  
Fax    
Email  rrgu04@gmail.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr BK Sharma Kaushik 
Designation  Vice Chancellor 
Affiliation  Guru Ravidas Ayurved University, Hoshiarpur, Punjab- 146001 
Address  Guru Ravidas Ayurved University, Hoshiarpur, Punjab- 146001
Guru Ravidas Ayurved University, Hoshiarpur, Punjab- 146001
Hoshiarpur
PUNJAB
146001
India 
Phone  9463369477  
Fax    
Email  acharyakaushik54@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rosy Gupta 
Designation  Reader 
Affiliation  Post Graduate Training and Research Institute Government Ayurvedic College Patiala 
Address  Reader in Post Graduate Training and Research Institute Government Ayurvedic College Patiala
Post Graduate Training and Research Institute Government Ayurvedic College Patiala
Patiala
PUNJAB
147001
India 
Phone  9815818190  
Fax    
Email  rrgu04@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Training and Research Institute Government Ayurvedic College Patiala 
 
Primary Sponsor  
Name  Post Graduate Training and Research Institute Government Ayurvedic College Patiala 
Address  Post Graduate Training and Research Institute Government Ayurvedic College Patiala Punjab 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Monika  Post Graduate Training and Research Institute Government Ayurvedic College Patiala  Dravyaguna Department Post Graduate Training and Research Institute Government Ayurvedic College Patiala Punjab
Patiala
PUNJAB 
9888246484

drmonika7076@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Bhumyamalaki and Kali maricha, Reference: Yog Ratanakar, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Luke warm water), Additional Information: Bhumyamalaki dose-6 gm TID Kali marich dose - 7 kali maricha in raw form coverted into churan form wth dose 500mg TID.
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient who will give written consent.
Patient having clinical features of Madhumeha according to Ayurvedic Classics.
Patient who are on oral hypoglycemic drugs but still having hyperglycemia. 
 
ExclusionCriteria 
Details  Patient who are insulin dependent.
Patient below 30 years and high chances of being DM type -1.
Gestational Diabetes Mellitus, Pregnancy. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To Assess the subjective symptoms like:
Prabhoota mutrata (polyuria)
Avila mutrata (Turbid urine)
Sthulata (Weight gain)
Shrama ( Fatigue)
 
1st day
8th day
15th day
30th day
 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the objective parameter like:
Blood sugar level 
1st day
8th day
15th day
30th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   30/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details
Modification(s)  
NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drmonika7076@gmail.com].

  6. For how long will this data be available start date provided 30-07-2021 and end date provided 30-07-2026?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  
Diabetes Mellitus is a clinical syndrome characterized by hyperglycemia due to absolute or relative deficiency of insulin. It is a leading cause of morbidity and mortality all over the world . The Prevalence of DM in India is currently reported to be around 13-15% and by 2025 it is estimated that approximately 55 million Indians will be Diabetic. The properties of  Bhumyamalaki and Kali maricha drug  have potential to treat the Madhumeha/DM more efficiently.
1. Total patients - 60 
2. Group - I & II
3. Present title- "A Comparative clinical study to evaluate the efficacy of Bhumyamalaki Churna and Kali Maricha Churna on Madhumeha w s r to Diabetes Mellitus".
4. Both drugs will be given for 30 days and will be analyzed on the basis of subjective and objective criteria.
 
Close